ENTO / Entero Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Entero Therapeutics, Inc.
US ˙ NasdaqCM ˙ US33749P1012

Deler fremragende 1,588,576 shares
Insideraktier596.480 shares
Insider ejerskab37,55 %
Total Insiders19
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

4827 out of 11305

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

4804 out of 11224

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Entero Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Matthew Balk 10% Owner - [10%] 1.627.796 162.780
Edward Borkowski Director - [D] 20.248 20.248
Charles J Casamento Director - [D] 19.937 19.937
Mary Theresa Coelho Director - [D] 20.237 20.237
Daniel Dupret CHIEF SCIENTIFIC OFFICER - [O] 15.000 1.500
David Andrew Hoffman Director - [D] 90.778 6.724
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Chaitan Phd Khosla Director - [D] 24.889 8.296
Gregory Oakes 34.482
Pelican Partners LLC 10% Owner - [10%] 1.627.796 162.780
James Pennington 7.500
Alastair Riddell Director - [D] 20.240 20.240
Sarah Romano Chief Financial Officer - [O] 17.287 5.762
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ross Edmund Burke Jr. 10% Owner - [10%] 2.540.555 254.056
James Sapirstein Chairman and CEO, Director - [D] [O] 35.816 11.939
Daniel H Schneiderman CHIEF FINANCIAL OFFICER - [O] 2.000 200
Vern Lee Schramm Director - [D] 90.498 9.050
Maged Shenouda CHIEF FINANCIAL OFFICER, Director - [D] [O] 62.500 6.250
Spoor Johan M. PRESIDENT AND CEO, Director - [D] [O] 338.617 33.862
Jack Syage President & COO, Director - [D] [O] 15.400 15.400

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ENTO / Entero Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-12-31 Ross Edmund Burke Jr. 23.848 1,1200 2.385 11,2000 26.710 128 28.943 42.291 158,34
2018-12-28 Shenouda Maged 20.000 1,3107 2.000 13,1070 26.214
2018-12-28 Ross Edmund Burke Jr. 29.575 1,1800 2.958 11,8000 34.898

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ENTO / Entero Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ENTO / Entero Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-01-06 Romano Sarah 727 0,6400 242 1,9200 465 114 0.3407 -383 -82,27
2024-10-09 Romano Sarah 476 0,4460 159 1,3380 212
2024-07-02 SAPIRSTEIN JAMES 1.289 1,0700 430 3,2100 1.379
2024-07-02 Romano Sarah 621 1,0700 207 3,2100 664
2024-04-01 Romano Sarah 75 4,2294 75 4,2294 317
2024-04-01 SAPIRSTEIN JAMES 174 4,2294 174 4,2294 736
2024-03-15 Romano Sarah 1.120 4,9600 1.120 4,9600 5.555
2024-03-15 SAPIRSTEIN JAMES 1.887 4,9600 1.887 4,9600 9.360
2024-01-12 SAPIRSTEIN JAMES 166 4,2000 166 4,2000 697

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ENTO / Entero Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-01-08 2025-01-06 4 Romano Sarah ENTO Common Stock S - Sale D 0,6400 -727 -0 17.287
2024-10-10 2024-10-09 4 Romano Sarah ENTO Common Stock S - Sale D 0,4460 -476 -0 18.014
2024-07-03 2024-07-02 4 Romano Sarah ENTO Common Stock S - Sale D 1,0700 -621 -1 18.490
2024-07-03 2024-07-02 4 SAPIRSTEIN JAMES ENTO Common Stock S - Sale D 1,0700 -1.289 -1 35.816
2024-06-12 2024-06-11 4 KHOSLA CHAITAN PHD ENTO Common Stock A - Award D 24.889 24.889
2024-04-03 2024-04-01 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 4,2294 -174 -1 37.105
2024-04-03 2024-04-01 4 Romano Sarah FWBI Common Stock S - Sale D 4,2294 -75 -0 19.111
2024-03-19 2024-03-15 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 4,9600 -1.887 -9 37.279
2024-03-19 2024-03-15 4 Romano Sarah FWBI Common Stock S - Sale D 4,9600 -1.120 -6 19.186
2024-03-15 2024-03-13 4 Syage Jack FWBI Common Stock, par value $0.0001 per share A - Award I 15.400 15.400
2024-03-15 2024-03-13 4 KHOSLA CHAITAN PHD FWBI Common Stock, par value $0.0001 per share A - Award I 440 440
2024-01-17 2024-01-12 4 Romano Sarah FWBI Common Stock S - Sale D 4,2000 -98 -0 20.306
2024-01-17 2024-01-12 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 4,2000 -166 -1 39.166
2024-01-04 2024-01-02 4 Coelho Mary Theresa FWBI Common Stock A - Award D 19.633 20.237
2024-01-04 2024-01-02 4 Riddell Alastair FWBI Common Stock A - Award D 19.633 20.240
2024-01-04 2024-01-02 4 CASAMENTO CHARLES J FWBI Common Stock A - Award D 19.633 19.937
2024-01-04 2024-01-02 4 BORKOWSKI EDWARD FWBI Common Stock A - Award D 19.633 20.248
2024-01-03 2024-01-02 4 SAPIRSTEIN JAMES FWBI Common Stock A - Award D 20.000 39.332
2024-01-03 2023-12-29 4 SAPIRSTEIN JAMES FWBI Common Stock A - Award D 17.660 19.332
2024-01-03 2024-01-02 4 Romano Sarah FWBI Common Stock A - Award D 7.000 20.404
2024-01-03 2023-12-29 4 Romano Sarah FWBI Common Stock A - Award D 12.614 13.404
2023-10-06 2023-10-04 4 Romano Sarah FWBI Common Stock S - Sale D 0,2900 -1.676 -0 15.800
2023-10-06 2023-10-04 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 0,2900 -2.764 -1 33.397
2023-09-18 2023-09-15 4 CASAMENTO CHARLES J FWBI Common Stock S - Sale D 0,4300 -10 -0 6.098
2023-09-05 2023-08-31 4 CASAMENTO CHARLES J FWBI Common Stock S - Sale D 0,3000 -6.053 -2 6.108
2023-07-05 2023-07-03 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 1,5400 -3.349 -5 36.161
2023-07-05 2023-07-03 4 Romano Sarah FWBI Common Stock S - Sale D 1,5400 -1.977 -3 17.476
2023-04-05 2023-04-03 4 Romano Sarah FWBI Common Stock S - Sale D 2,5000 -1.975 -5 19.453
2023-04-05 2023-04-03 4 SAPIRSTEIN JAMES FWBI Common Stock S - Sale D 2,5000 -3.347 -8 39.510
2023-01-05 2023-01-03 4 Riddell Alastair FWBI Common Stock A - Award D 84.745 85.185
2023-01-05 2023-01-03 4 Hoffman David Andrew FWBI Common Stock A - Award D 84.745 90.778
2023-01-05 2023-01-03 4 CASAMENTO CHARLES J FWBI Common Stock A - Award D 84.745 85.134
2023-01-05 2023-01-03 4 BORKOWSKI EDWARD FWBI Common Stock A - Award D 84.745 86.156
2023-01-05 2023-01-03 4 SAPIRSTEIN JAMES FWBI Common Stock A - Award D 300.000 300.000
2023-01-05 2023-01-03 4 Romano Sarah FWBI Common Stock A - Award D 150.000 150.000
2023-01-05 2023-01-03 4 Coelho Mary Theresa FWBI Common Stock A - Award D 84.745 84.745
2022-05-04 3 Hoffman David Andrew FWBI Common Stock D 181.000
2022-03-02 2022-03-01 4 Romano Sarah FWBI Stock option (right to buy) A - Award D 1,18 150.000 150.000
2022-01-03 2022-01-03 4 Oakes Gregory FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2022-01-03 2022-01-03 4 Schramm Vern Lee FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2022-01-03 2022-01-03 4 Schneiderman Daniel H FWBI Stock option (right to buy) A - Award D 1,45 10.000 10.000
2022-01-03 2022-01-03 4 SAPIRSTEIN JAMES FWBI Stock option (right to buy) A - Award D 1,45 150.000 150.000
2022-01-03 2022-01-03 4 Pennington James FWBI Stock option (right to buy) A - Award D 1,45 7.500 7.500
2022-01-03 2022-01-03 4 Riddell Alastair FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2022-01-03 2022-01-03 4 Coelho Mary Theresa FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2022-01-03 2022-01-03 4 BORKOWSKI EDWARD FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2022-01-03 2022-01-03 4 CASAMENTO CHARLES J FWBI Stock option (right to buy) A - Award D 1,45 34.482 34.482
2021-09-13 2021-09-09 4 Coelho Mary Theresa AZRX Stock option (right to buy) A - Award D 0,64 10.310 10.310
2021-07-09 2021-07-09 4 Pennington James AZRX Stock option (right to buy) A - Award D 0,75 100.000 100.000
2021-07-02 2021-06-30 4 SAPIRSTEIN JAMES AZRX Stock options (right to buy) A - Award D 0,85 900.000 900.000
2021-07-02 2021-06-30 4 SAPIRSTEIN JAMES AZRX Stock options (right to buy) J - Other D 0,85 -900.000 300.000
2021-07-02 2021-06-30 4 Schneiderman Daniel H AZRX Stock option (right to buy) A - Award D 0,85 250.000 250.000
2021-07-02 2021-06-30 4 Schneiderman Daniel H AZRX Stock option (right to buy) J - Other D 0,85 -250.000 0
2021-07-02 2021-06-30 4 Schneiderman Daniel H AZRX Stock option (right to buy) A - Award D 0,85 35.006 35.006
2021-07-02 2021-06-30 4 Schneiderman Daniel H AZRX Stock option (right to buy) J - Other D 0,85 -35.006 0
2021-01-06 2021-01-04 4 Oakes Gregory AZRX Options (right to buy) A - Award D 0,97 41.237 41.237
2021-01-06 2021-01-04 4 Schramm Vern Lee AZRX Options (right to buy) A - Award D 0,97 41.237 41.237
2021-01-06 2021-01-04 4 Riddell Alastair AZRX Options (right to buy) A - Award D 0,97 41.237 41.237
2021-01-06 2021-01-04 4 CASAMENTO CHARLES J AZRX Options (right to buy) A - Award D 0,97 41.237 41.237
2021-01-06 2021-01-04 4 BORKOWSKI EDWARD AZRX Options (right to buy) A - Award D 0,97 41.237 41.237
2020-07-20 2020-07-16 4 SAPIRSTEIN JAMES AZRX Series B Warrants A - Award D 0,85 64.935 64.935
2020-07-20 2020-07-16 4 SAPIRSTEIN JAMES AZRX Series B Convertible Preferred Stock A - Award D 0,77 13 13
2020-07-20 2020-07-16 4 SAPIRSTEIN JAMES AZRX Stock options (right to buy) A - Award D 0,85 1.200.000 1.200.000
2020-07-20 2020-07-16 4 Schneiderman Daniel H AZRX Stock option (right to buy) A - Award D 0,85 250.000 250.000
2020-07-20 2020-07-16 4 Schneiderman Daniel H AZRX Stock option (right to buy) A - Award D 0,85 35.006 35.006
2020-07-20 2020-07-16 4 Schneiderman Daniel H AZRX Stock option (right to buy) J - Other D 1,03 -35.006 300.000
2020-07-20 2020-07-16 4 BORKOWSKI EDWARD AZRX 9.0% Senior Convertible Promissory Note D - Sale to Issuer D 1,07 -100.000 0
2020-07-20 2020-07-16 4 BORKOWSKI EDWARD AZRX Exchange Warrants A - Award D 0,85 25.774 25.774
2020-07-20 2020-07-16 4 BORKOWSKI EDWARD AZRX Series B Warrants A - Award D 0,85 230.602 230.602
2020-07-20 2020-07-16 4 BORKOWSKI EDWARD AZRX Series B Convertible Preferred Stock A - Award D 0,77 46 46
2020-07-20 2019-06-13 4 Pennington James AZRX Stock option (right to buy) A - Award D 1,75 110.000 110.000
2020-07-20 2020-07-16 4 Pennington James AZRX Stock option (right to buy) A - Award D 0,85 300.000 300.000
2020-06-01 2020-06-01 4 BORKOWSKI EDWARD AZRX 9.0% Senior Convertible Promissory Note A - Award D 1,07 100.000,0000
2020-06-01 2020-06-01 4 BORKOWSKI EDWARD AZRX 9.0% Senior Convertible Promissory Note D - Sale to Issuer D 0,97 100.000,0000 0
2020-04-16 2020-04-13 4 Oakes Gregory AZRX Options A - Award D 0,97 60.000 60.000
2020-04-07 2020-04-06 4 Schramm Vern Lee AZRX Options A - Award D 0,97 80.000 80.000
2020-04-07 2020-04-06 4 CASAMENTO CHARLES J AZRX Options A - Award D 0,97 80.000 80.000
2020-04-07 2020-04-06 4 Spoor Johan M. AZRX Options A - Award D 0,97 80.000 80.000
2020-04-07 2020-04-06 4 Riddell Alastair AZRX Options A - Award D 0,97 80.000 80.000
2020-04-07 2020-04-06 4 BORKOWSKI EDWARD AZRX Options A - Award D 0,97 80.000 80.000
2020-03-23 2020-03-19 4 CASAMENTO CHARLES J La Jolla Lenox Trust AZRX Common Stock G - Gift I 9.000 116.998
2020-03-23 2020-03-19 4 CASAMENTO CHARLES J AZRX Common Stock G - Gift D -9.000 107.998
2020-03-13 2020-03-10 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 4,7400 6.330 30 409.773
2020-03-13 2020-03-10 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 4,7400 1.319 6 403.443
2020-03-13 2020-03-10 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 1,0400 8.414 9 402.124
2020-03-13 2020-03-10 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 0,6000 14.584 9 393.710
2020-03-13 2020-03-11 4 Schramm Vern Lee AZRX Common Stock A - Award D 1,0400 8.414 9 90.498
2020-03-13 2020-03-11 4 Schramm Vern Lee AZRX Common Stock A - Award D 0,6000 14.584 9 82.084
2020-03-13 2020-03-11 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 1,0400 8.414 9 116.998
2020-03-13 2020-03-11 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 0,6000 14.584 9 108.584
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 1,0400 8.414 9 132.049
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 0,6000 14.584 9 123.635
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 3,6300 2.755 10 106.296
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 3,9900 2.507 10 103.541
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 4,7400 264 1 101.034
2020-03-13 2020-03-11 4 Riddell Alastair AZRX Common Stock A - Award D 4,7400 770 4 100.770
2020-01-29 2020-01-02 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX 10% Convertible Note Due 2020 J - Other I 2,50 1.000.000,0000 0
2020-01-29 2020-01-02 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX 10% Convertible Note Due 2019 J - Other I 2,50 1.000.000,0000 0
2020-01-09 2020-01-02 4 Schneiderman Daniel H AZRX Options A - Award D 1,03 335.006 335.006
2020-01-09 3 Schneiderman Daniel H AZRX Common Stock D 2.000
2020-01-09 3 Schneiderman Daniel H AZRX Common Stock D 2.000
2020-01-09 3 Schneiderman Daniel H AZRX Common Stock D 2.000
2020-01-03 2019-12-31 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 1,0400 7.500 8 379.126
2020-01-03 2019-12-20 4 BORKOWSKI EDWARD AZRX 9.0% Senior Convertible Promissory Note A - Award D 0,97 103.094
2020-01-03 2019-12-20 4 BORKOWSKI EDWARD AZRX Warrants A - Award D 1,07 51.547 103.094
2020-01-03 2019-12-31 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 1,0400 7.500 8 94.000
2020-01-03 2019-12-31 4 Riddell Alastair AZRX Common Stock A - Award D 1,0400 7.500 8 100.000
2020-01-03 2019-12-31 4 Schramm Vern Lee AZRX Common Stock A - Award D 1,0400 7.500 8 67.500
2019-10-10 2019-10-08 4 SAPIRSTEIN JAMES AZRX Options A - Award D 0,52 300.000 300.000
2019-10-10 2019-10-08 4 SAPIRSTEIN JAMES AZRX Common Stock A - Award D 200.000 200.000
2019-10-01 2019-09-30 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 0,6000 7.500 4 371.626
2019-10-01 2019-09-30 4 Schramm Vern Lee AZRX Common Stock A - Award D 0,6000 7.500 4 60.000
2019-10-01 2019-09-30 4 CASAMENTO CHARLES J AZRX Common A - Award D 0,6000 7.500 4 86.500
2019-10-01 2019-09-30 4 Riddell Alastair AZRX Common Stock A - Award D 0,6000 7.500 4 92.500
2019-07-02 2019-06-30 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 1,7000 7.500 13 364.126
2019-07-02 2019-06-30 4 Schramm Vern Lee AZRX Common Stock A - Award D 1,7000 7.500 13 52.500
2019-07-02 2019-06-30 4 CASAMENTO CHARLES J AZRX Common A - Award D 1,7000 7.500 13 79.000
2019-07-02 2019-06-30 4 Riddell Alastair AZRX Common Stock A - Award D 1,7000 7.500 13 85.000
2019-06-21 2019-06-13 4/A Schramm Vern Lee AZRX Options A - Award D 1,75 30.000 30.000
2019-06-21 2019-06-13 4/A Riddell Alastair AZRX Options A - Award D 1,75 30.000 30.000
2019-06-21 2019-06-13 4/A BORKOWSKI EDWARD AZRX Options A - Award D 1,75 30.000 30.000
2019-06-21 2019-06-13 4/A CASAMENTO CHARLES J AZRX Options A - Award D 1,75 30.000 30.000
2019-06-17 2019-06-13 4 Schramm Vern Lee AZRX Common Stock A - Award D 30.000 75.000
2019-06-17 2019-06-13 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 30.000 386.626
2019-06-17 2019-06-13 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 30.000 101.500
2019-06-17 2019-06-13 4 Riddell Alastair AZRX Common Stock A - Award D 30.000 107.500
2019-04-29 2019-03-31 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 2,4200 7.500 18 356.626
2019-04-29 2019-03-31 4 Schramm Vern Lee AZRX Common Stock A - Award D 2,4200 7.500 18 45.000
2019-04-29 2019-03-31 4 Riddell Alastair AZRX Common Stock A - Award D 2,4200 7.500 18 77.500
2019-04-29 2019-03-31 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 2,4200 7.500 18 71.500
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by CEDA Investments, LLC AZRX CEDA Warrants Expiring 2020 P - Purchase I 1,50 21.429 21.429
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by CEDA Investments, LLC AZRX CEDA Warrants Expiring 2020 H - Other I 5,50 -21.429 0
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by EBR Ventures, LLC AZRX EBR Warrants Expiring 2020 P - Purchase I 1,50 100.000 75.000
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by EBR Ventures, LLC AZRX EBR Warrants Expiring 2020 H - Other I 5,50 -100.000 0
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX ADEC Warrants Expiring 2021 P - Purchase I 1,50 371.143 371.143
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX ADEC Warrants Expiring 2021 H - Other I 5,50 -371.143 0
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX ADEC Warrants Expiring 2020 P - Purchase I 1,50 273.598 273.598
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX ADEC Warrants Expiring 2020 H - Other I 5,58 -273.598 0
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX 10% Convertible Note Due 2020 P - Purchase I 2,50 1.000.000,0000 1.000.000 1.000.000.000 1.000.000
2019-02-19 2019-02-14 4 Ross Edmund Burke Jr. owned by ADEC Private Equity Investments, LLC AZRX 10% Convertible Note Due 2019 P - Purchase I 2,50 1.000.000,0000 1.000.000 1.000.000.000 1.000.000
2019-01-07 2018-12-31 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 1,1200 23.848 27 2.540.555
2019-01-07 2018-12-28 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 1,1800 29.575 35 2.516.707
2019-01-07 2018-12-27 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 1,1300 23.200 26 2.487.132
2019-01-07 2018-12-27 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 1,1800 42.922 51 2.463.932
2019-01-07 2018-05-02 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 2,5000 20.000 50 2.421.010
2019-01-02 2018-12-28 4 Spoor Johan M. AZRX Common Stock P - Purchase D 1,2951 38.583 50 338.617
2019-01-02 2018-12-28 4 Shenouda Maged AZRX Common Stock P - Purchase D 1,3107 20.000 26 62.500
2019-01-02 2018-12-28 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 1,2900 7.500 10 64.000
2019-01-02 2018-12-28 4 CASAMENTO CHARLES J AZRX Common Stock P - Purchase D 1,4100 9.000 13 56.500
2019-01-02 2018-12-28 4 Schramm Vern Lee AZRX Common Stock A - Award D 1,2900 7.500 10 37.500
2019-01-02 2018-12-28 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 1,2900 7.500 10 349.126
2019-01-02 2018-12-28 4 Riddell Alastair AZRX Common Stock A - Award D 1,2900 7.500 10 70.000
2018-10-01 2018-09-28 4 Schramm Vern Lee AZRX Common Stock A - Award D 2,5700 7.500 19 30.000
2018-10-01 2018-09-28 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 2,5700 7.500 19 341.626
2018-10-01 2018-09-28 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 2,5700 7.500 19 47.500
2018-10-01 2018-09-28 4 Riddell Alastair AZRX Common Stock A - Award D 2,5700 7.500 19 62.500
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Warrants M - Exercise D 2,50 -8.640 28.474
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Warrants M - Exercise D 2,50 -13.680 0
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Warrants M - Exercise D 2,50 -13.680 0
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Common Stock M - Exercise D 2,5000 13.680 34 319.126
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Common Stock M - Exercise D 2,5000 13.680 34 305.446
2018-07-26 2018-01-11 4/A BORKOWSKI EDWARD AZRX Common Stock M - Exercise D 2,5000 8.640 22 291.766
2018-07-26 2018-06-29 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 7.500 334.126
2018-07-19 2018-07-12 4 Pennington James AZRX Options A - Award D 3,04 75.000 75.000
2018-07-18 2018-07-12 4 Dupret Daniel AZRX Options A - Award D 3,04 60.000 60.000
2018-07-18 2018-07-12 4 Dupret Daniel AZRX Common Stock A - Award D 15.000 15.000
2018-07-16 2018-07-12 4 Spoor Johan M. AZRX Common Stock A - Award D 200.000 300.034
2018-07-16 2018-06-30 4 Schramm Vern Lee AZRX Common Stock A - Award D 7.500 22.500
2018-07-16 2018-07-12 4 Shenouda Maged AZRX Options A - Award D 3,04 100.000 100.000
2018-07-16 2018-06-29 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 7.500 40.000
2018-07-16 2018-06-29 4 Riddell Alastair AZRX Common Stock A - Award D 7.500 55.000
2018-04-02 2018-03-29 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 3,1400 7.500 24 305.446
2018-04-02 2018-03-29 4 Riddell Alastair AZRX Common Stock A - Award D 3,1400 7.500 24 47.500
2018-04-02 2018-03-29 4 Schramm Vern Lee AZRX Common Stock A - Award D 3,1400 7.500 24 15.000
2018-04-02 2018-03-29 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 3,1400 7.500 24 32.500
2018-02-13 2017-12-20 5 Schramm Vern Lee AZRX Common Stock A - Award D 7.500 7.500
2018-02-13 2017-12-20 5 Riddell Alastair AZRX Common Stock A - Award D 7.500 40.000
2018-02-13 2017-12-20 5 BORKOWSKI EDWARD AZRX Common Stock A - Award D 7.500 305.446
2018-02-13 2017-12-20 5 CASAMENTO CHARLES J AZRX Common Stock A - Award D 7.500 25.000
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD AZRX Warrants M - Exercise D 2,50 -8.640 28.474
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD AZRX Warrants M - Exercise D 2,50 -13.680 0
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD By Spouse AZRX Warrants M - Exercise I 2,50 -13.680 0
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD AZRX Common Stock M - Exercise D 2,5000 13.680 34 13.680
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD By Spouse AZRX Common Stock M - Exercise I 2,5000 13.680 34 13.680
2018-01-16 2018-01-11 4 BORKOWSKI EDWARD AZRX Common Stock M - Exercise D 2,5000 8.640 22 284.266
2017-11-14 2017-11-10 4 Spoor Johan M. AZRX Options X - Other D 1,00 -100.000 200.000
2017-11-14 2017-11-10 4 Spoor Johan M. AZRX Common Stock X - Other D 1,0000 100.000 100 100.034
2017-11-01 2017-10-19 4 BORKOWSKI EDWARD AZRX Common Stock A - Award D 22.500 275.626
2017-10-23 2017-10-19 4 Shenouda Maged AZRX Common Stock A - Award D 22.500 42.500
2017-10-23 2017-10-19 4 CASAMENTO CHARLES J AZRX Common Stock A - Award D 17.500 17.500
2017-10-23 2017-10-19 4 Riddell Alastair AZRX Common Stock A - Award D 22.500 32.500
2017-09-27 2017-09-25 4 Shenouda Maged AZRX Options A - Award D 4,39 100.000 100.000
2017-07-05 2017-06-30 4/A Pelican Partners LLC AZRX Common Stock S - Sale D 3,5000 -60.000 -210 1.627.796
2017-07-05 2017-06-30 4/A Pelican Partners LLC AZRX Common Stock S - Sale D 3,0000 -100.000 -300 1.687.796
2017-07-03 2017-06-30 4 Pelican Partners LLC AZRX Common Stock S - Sale D 3,5000 -60.000 -210 1.727.796
2017-07-03 2017-06-30 4 Pelican Partners LLC AZRX Common Stock S - Sale D 3,0000 -100.000 -300 1.787.796
2017-06-09 2017-06-05 4 Ross Edmund Burke Jr. AZRX Series A-1 Warrants P - Purchase D 5,50 128.572 96.429
2017-06-09 2017-06-05 4 Ross Edmund Burke Jr. AZRX Series A Warrants P - Purchase D 4,00 128.572 96.429
2017-06-09 2017-06-05 4 Ross Edmund Burke Jr. AZRX Common Stock P - Purchase I 3,5000 128.572 450 1.659.840
2017-02-07 2017-02-03 4 Riddell Alastair AZRX Options A - Award D 4,48 30.000 30.000
2017-02-07 2017-02-03 4 BORKOWSKI EDWARD AZRX Options A - Award D 4,48 30.000 30.000
2017-02-07 2017-02-03 4 Spoor Johan M. AZRX Options A - Award D 4,48 100.000 100.000
2017-02-07 2017-02-03 4 Shenouda Maged AZRX Options A - Award D 4,48 30.000 30.000
2016-10-18 2016-10-14 4 Ross Edmund Burke Jr. By ADEC Private Equity Investment, LLC AZRX Original Issuance Discount Convertible Notes C - Conversion I 4,65 0
2016-10-18 2016-10-14 4 Ross Edmund Burke Jr. By ADEC Private Equity Investment, LLC AZRX Warrants J - Other I 5,50 371.142 371.142
2016-10-18 2016-10-14 4 Ross Edmund Burke Jr. AZRX Common Stock C - Conversion I 4,6500 1.031.268 4.795 1.531.268
2016-10-14 2016-10-11 4 Pelican Partners LLC AZRX Common Stock G - Gift D -15.350 1.787.796
2016-10-11 3 BORKOWSKI EDWARD AZRX Common Stock D 300.000
2016-10-11 3 BORKOWSKI EDWARD AZRX Common Stock D 300.000
2016-10-11 3 Ross Edmund Burke Jr. By EBR Ventures, LLC AZRX Common Stock I 1.000.000
2016-10-11 3 Ross Edmund Burke Jr. By EBR Ventures, LLC AZRX Common Stock I 1.000.000
2016-10-11 3 Shenouda Maged AZRX Common Stock D 40.000
2016-10-11 3 Shenouda Maged AZRX Common Stock D 40.000
2016-10-11 3 BALK MATTHEW AZRX Common Stock D 3.606.292
2016-10-11 3 BALK MATTHEW AZRX Common Stock D 3.606.292
2016-10-11 3 BALK MATTHEW AZRX Common Stock D 3.606.292
2016-10-11 3 Spoor Johan M. AZRX Common Stock D 39.919
2016-10-11 3 Spoor Johan M. Held by trust AZRX Common Stock I 79.736
2016-10-11 3 Spoor Johan M. AZRX Common Stock D 39.919
2016-10-11 3 Spoor Johan M. Held by trust AZRX Common Stock I 79.736
2016-10-11 3 Riddell Alastair AZRX Common Stock D 20.000
2016-10-11 3 Riddell Alastair AZRX Common Stock D 20.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista